Skip to main content

Personalized CAR T Cell Therapy™

Learn More Today

in the media

Lentigen Technology Inc., a Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma, Inc.

Lentigen Technology Inc., a leading provider of GMP lentiviral vectors, will further advance Living Pharma’s personalized chimeric antigen receptor (...

July 20, 2017

Living Pharma Adds Noted Oncologist to its Advisory Board

Living Pharma, Inc. announced today that it has added Aaron P. Rapoport, MD, to its advisory board.

November 1, 2016

Living Pharma Adds Venture Capital Executive to its Advisory Board

Living Pharma, Inc. announced today that it has added Isai Peimer, PhD, to its advisory board.

June 1, 2016

Living Pharma Signs Exclusive License Agreement with UMB for a Novel Universal CAR T Cell Platform Technology

Living Pharma, Inc. announced today that it has entered into an exclusive license agreement with the University of Maryland, Baltimore (UMB) to...

January 28, 2016

contact form

info@livingpharma.com     general email

To learn more about Living Pharma and our investor opportunities, please complete our contact form.